logo
Sweetgreen abandons tiered loyalty for points-based program

Sweetgreen abandons tiered loyalty for points-based program

Yahoo04-04-2025

This story was originally published on Restaurant Dive. To receive daily news and insights, subscribe to our free daily Restaurant Dive newsletter.
Sweetgreen has launched a points-based loyalty program, SG Rewards, to replace Sweetpass, a tiered subscription program that consumers found too complicated, the company announced in a Thursday press release.
SG members earn 10 points for every dollar spent, and get access to unspecified perks and members-only deals. The points can be redeemed for entrees or sides, according to the press release.
CEO Jonathan Neman said during a February earnings call that the loyalty shift would help improve Sweetgreen's value proposition — a vital consideration as consumers remain price sensitive and economic confidence falters.
Sweetgreen's new program has been in the works since last year. The program was created in response to consumer desire for a more flexible rewards program, Neman said in a statement.
'SG Rewards offers more value, more flexibility and more ways to enjoy Sweetgreen — from everyday surprise & delight moments to members-only deals and special perks,' Neman said.
The Sweetpass program that preceded SG Rewards included consumer challenges and a subscription tier, which cost members $100 annually, that gave consumers $3 discounts on orders.
To promote adoption of the new program, the salad brand is offering some time-limited perks. Consumers who sign up and complete a purchase in April will receive 1,000 bonus points, equivalent to the amount earned after $100 in spend. Existing members who make an eligible purchase before April 11 will also receive 1,000 bonus points. Those bonus points are enough to earn an order of the company's air-fried Ripple Fries, which were introduced in March, according to the press release.
On the earnings call, Neman said he expected the new program — combined with investments in menu innovation and personalized offers — would result in transaction growth.
Sweetgreen managed positive comps and traffic last year, Chief Financial Officer Mitch Reback said on the brand's earnings call. Full-year traffic rose 2%, while same-store sales increased a total of 6%.
Those numbers were impressive, given the stagnation of same-store sales at many brands, but lagged behind some fast casual competitors, like Chipotle and Cava. Nonetheless, the brand still posted a $90 million net loss for fiscal 2024, according to its 10-K, though that was an improvement over its $113 million net loss in 2023.
While Sweetgreen is still the segment leader for fast casual salads, there are other chains looking to unseat it. Just Salad, in particular, has made moves that resemble Sweetgreen's in recent months. Just Salad added heartier options focused on the dinner daypart, debuting drive-thrus and raising $200 million in capital. If 2025 brings Sweetgreen strong traffic, the salad chain could separate itself from competitors, especially if consumer confidence in the category continues to crumble as a result of macroeconomic uncertainty.
Recommended Reading
Sweetgreen to launch points-based loyalty program

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Billionaires Ken Griffin and Israel Englander Are Buying a Beaten-Down Growth Stock -- and It Could Turn $10,000 Into $100,000
Billionaires Ken Griffin and Israel Englander Are Buying a Beaten-Down Growth Stock -- and It Could Turn $10,000 Into $100,000

Yahoo

time7 hours ago

  • Yahoo

Billionaires Ken Griffin and Israel Englander Are Buying a Beaten-Down Growth Stock -- and It Could Turn $10,000 Into $100,000

Billionaires like Ken Griffin and Israel Englander piled into Sweetgreen stock in the first quarter. After posting disappointing results this year and facing macro headwinds, the stock has plunged. The long-term growth opportunity for Sweetgreen is still substantial. 10 stocks we like better than Sweetgreen › Sweetgreen (NYSE: SG) is one of the more disruptive companies in the retail/restaurant industry today. The company has brought a new concept to the fast-casual format as the largest fast-casual salad chain in the U.S. That menu seems to be resonating with customers. Sweetgreen is rapidly adding new locations, and its average restaurant brings in $2.9 million in revenue, a number on par with fast-casual leader Chipotle. However, an even greater point of disruption from Sweetgreen may be its Infinite Kitchen, a robotic system to help expedite orders, saving money on labor and improving throughput. Of the 40 restaurants it plans to open this year, 20 will have an Infinite Kitchen. The company has also teased the idea of licensing the new technology, which could open up a new revenue stream. Despite that potential, Sweetgreen has had a forgettable year. Its stock is down 54% year to date through June 4. It has faced several challenges, including the wildfires in Los Angeles, one of its biggest markets and where the company is headquartered, and broader headwinds in the restaurant industry due to concerns about tariffs and other signs of a weakening economy. In its first-quarter earnings report, the company reported a same-store sales decline of 3.1%. It said quarter-to-date comps were down mid-single digits in the second quarter as concerns around tariffs picked up in April, weighing on demand. A 54% sell-off is disappointing for existing shareholders of the stock, but it creates an opportunity to scoop up this promising growth stock on the cheap. In fact, two billionaires did just that in the first quarter. Israel Englander's Millennium Management purchased 2.17 million shares of the restaurant stock, adding to a stake it started building in Q1 2023. Similarly, Ken Griffin's Citadel Advisors, which is often considered to be the best-performing hedge fund, added 1.27 million shares of Sweetgreen. Citadel first bought the stock when it went public in the fourth quarter of 2021. Buying the dip on Sweetgreen is risky, especially with an uncertain economy, and declining comparable sales are never a good sign for a restaurant chain. However, management's guidance calls for an improvement in same-store sales over the rest of the year, forecasting flat growth for the year. More importantly, the company's long-term growth opportunities are still significant. After the reset in the stock price, Sweetgreen's market cap has fallen to just $1.8 billion. That means the stock could turn $10,000 to $100,000 if its market cap reached $18 billion, a reasonable goal for a restaurant chain. Despite the weak same-store sales, Sweetgreen continues to aggressively open new stores. It plans to add 40 locations this year, growing the store base by 16%. Over the longer term, CEO Jonathan Neman sees the company growing to at least 1,000 stores, if not several thousand. This should drive the stock higher over the longer term, assuming Sweetgreen can pull off that expansion. In the meantime, the company is delivering strong average unit volumes of $2.9 billion, and its restaurant-level operating margin of 19% is good enough to drive profitability, especially as that margin is likely to increase over time. Investments in the Infinite Kitchen system seemed to have weighed on the bottom line but should spread out over time. Finally, Infinite Kitchen should give the company a competitive advantage in areas like labor and throughput, and the effect of the technology should eventually show in the financial results. Overall, Sweetgreen is the leader in a growing fast-casual category, its restaurants are generating strong traffic, and it has a potential technological advantage in Infinite Kitchen. The stock is risky, but the upside potential is there, especially once the economy improves. The company should return to same-store sales growth when that happens. Before you buy stock in Sweetgreen, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Sweetgreen wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!* Now, it's worth noting Stock Advisor's total average return is 792% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Jeremy Bowman has positions in Chipotle Mexican Grill and Sweetgreen. The Motley Fool has positions in and recommends Chipotle Mexican Grill. The Motley Fool recommends Sweetgreen and recommends the following options: short June 2025 $55 calls on Chipotle Mexican Grill. The Motley Fool has a disclosure policy. Billionaires Ken Griffin and Israel Englander Are Buying a Beaten-Down Growth Stock -- and It Could Turn $10,000 Into $100,000 was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

BJ's Restaurants appoints CEO
BJ's Restaurants appoints CEO

Yahoo

time3 days ago

  • Yahoo

BJ's Restaurants appoints CEO

This story was originally published on Restaurant Dive. To receive daily news and insights, subscribe to our free daily Restaurant Dive newsletter. BJ's Restaurants has promoted Lyle D. Tick to CEO and president, effective Thursday, the company said in a press release. In addition, the company's CFO, Thomas A. Houdek, will resign from his post on June 20. Tick, current president and chief concept officer, will succeed interim CEO C. Bradford Richmond, who will become special advisor to the CEO during Tick's transition. Richmond will remain a member of the board of directors. Tick joined BJ's Restaurants in September 2024, after serving as president and CEO at On the Border Mexican Grill & Cantina. He has played a key role in creating BJ's strategic vision, that is focused on the employee experience, menu and improved hospitality. BJ's Restaurants, which posted 1.7% same-store sales growth in Q1, has been without a permanent CEO since Gregory S. Levin stepped down from the role in late August. Levin was with the company for 19 years and became CEO in 2021. William Blair analyst Sharon Zackfia said Tick's promotion was 'unsurprising' and 'largely expected.' Tick has experience turning a brand around and driving sales. For roughly five years as brand president at Buffalo Wild Wings, Tick led a revitalization effort that included 'a return to its sport bar legacy, an updated design, and a revamped menu alongside the launch of the smaller delivery/takeout concept Buffalo Wild Wings GO,' Zackfia said. In the months since joining BJ's, Tick already has made a big impression. 'As President and Chief Concept Officer, Lyle has quickly re-focused the Company's core sales and profit-driving initiatives to further differentiate our concept while capturing opportunities to reduce operational complexity,' Lea Anne S. Ottinger, BJ's board chair, said in a statement. 'We are confident that under his leadership, BJ's will continue to drive sustainable growth and create long-term shareholder value.' The company's ongoing strategy to drive sales includes menu innovation, like its Pizookie Meal Deal, Tick said in the company's Q1 2025 earnings release. That item improved the chain's value proposition, he said during an earnings call. A Pizookie Platter, which combined four regular sized Pizookie's into one treat, gained significant play on social media, generating 57 million organic social impressions. The chain sold more than 24,000 platters, Tick said. Menu innovation contributed to a 2.7% traffic bump during the quarter. The chain also has been working on improving team member experience, such as updating its point-of-sales and kitchen display systems that can help employees input menu items, boost accuracy and speed of service. This has helped reduce comping of food and beverages by 13% year over year, Tick said. Recommended Reading BJ's Restaurants CEO, president Gregory Levin steps down

NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs
NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs

Yahoo

time4 days ago

  • Yahoo

NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs

USC brain tumor authority to accelerate four clinical trials including lead asset NEO100 nearing Phase 2a completion ahead of schedule Appointment bolsters FDA approval path while company explores AI and quantum computing to enhance drug delivery platform CALABASAS, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous system (CNS) cancers and disorders, today announced the appointment of Josh Neman, PhD as its new Chief Clinical Officer (CCO). Dr. Neman brings with him a distinguished career at the intersection of cancer neuroscience, translational research, and academic medicine. Dr. Neman joins NeOnc Technologies Holdings Inc. (NeOnc) from the Keck School of Medicine at the University of Southern California (USC), where he serves as Associate Professor of Neurological Surgery and Physiology & Neuroscience, and Scientific Director of the USC Brain Tumor Center. At USC, he also leads the Cancer Biology and Genomics PhD Program and serves as Director of Cancer Research Training and Education Coordination at the USC Norris Comprehensive Cancer Center- a leading National Cancer Institute-designated cancer research hospital. A nationally recognized leader in neurooncological sciences and cancer neuroscience, Dr. Neman's research has advanced the understanding of how brain microenvironments influence the progression of brain tumors and metastases. His pioneering studies on tumor-neuron interactions, GABAergic signaling in cancer, and mechanisms of leptomeningeal dissemination have helped shape new therapeutic paradigms for both adult and pediatric brain tumors. 'I am deeply honored to join NeOnc at this exciting time,' said Dr. Neman. 'NeOnc's commitment to developing innovative therapeutics, including Blood Brain Barrier-penetrant compounds like NEO212 and NEO100, aligns perfectly with my lifelong passion to improve outcomes for patients with brain tumors. I look forward to helping lead the translation of promising discoveries from the lab into meaningful clinical impact.' In his role as Chief Clinical Officer, Dr. Neman will lead NeOnc's clinical development strategy, including investigator-initiated trials and precision oncology partnerships. He will also play a key role in expanding NeOnc's research collaborations with academic institutions, regulatory agencies, and patient advocacy groups. 'Dr. Neman's appointment signals a major step forward in NeOnc's mission to transform the treatment landscape for patients with life-threatening cancers with poor outcomes,' said Amir Heshmatpour, Executive Chairman and President of NeOnc Technologies Holdings, Inc. 'His academic and clinical leadership, coupled with his deep expertise in brain tumor biology, will be instrumental in accelerating all four of our clinical trials—especially our lead asset, NEO100, which is approaching the completion of its Phase 2a trial with full enrollment achieved ahead of schedule. As we look to add AI and quantum computing into our expanding platform in drug delivery and bio-conjugation, Dr. Neman's appointment further strengthens our commitment to advancing precision therapies and driving toward FDA approval.' About NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI): NeOnc Technologies is a publicly traded, clinical-stage biopharmaceutical company developing innovative therapies for brain and central nervous system cancers. Its lead programs—NEO100-01, NEO100-02, NEO100-03, and NEO212—utilize proprietary formulations to bypass the blood-brain barrier and target malignancies with precision. The company's IP portfolio includes 176 patents worldwide, reflecting a broad platform with strong commercialization potential. For more about NeOnc and its pioneering technology, visit Important Cautions Regarding Forward-Looking Statements All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Generally, such forward-looking statements include statements regarding expectations, possible or assumed future actions, business strategies, events or results of operations, including statements regarding expectations or predictions or future financial or business performance or conditions and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate," or similar expressions. The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties, and assumptions. Actual results could differ materially from current projections or implied results. The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management are under no obligation, and expressly disclaim any obligation, to update, alter or otherwise revise any forward-looking statements following the date of this news release, whether because of new information, future events or otherwise, except as required by law. 'NEO100' is a registered trademark of NeOnc Technologies Holdings, Inc. Company Contact:23975 Sorrento Park Suite 205, Calabasas, CA, 91302info@ Investor Relations:James CarbonaraHayden IR369 Lexington AvenueSecond FloorNew York, NY 10017Office: (646)-755-7412James@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store